Virtual Hub On-Demand

Oct
07

COVID-19 and Its Impact on Patient Care in IBD: What Clinicians Need to Know

This OnDemand webcast provides clinicians with the latest information and consensus recommendations for the management of patients with IBD during the COVID-19 era. Expert faculty will also examine the latest evidence on treatment and prevention strategies for COVID-19.

Read More
By Ben Stoner |
DETAIL
Jul
02

The Road to Remission: Assessing Today’s Treatment Goals in Crohn’s Disease

In Crohn’s disease (CD), an inflammatory bowel disease (IBD) that affects at least 780,000 people in the United States, management goals have recently evolved from controlling symptoms to early treatment and achieving endoscopic and histologic remission, which can help a patient avoid progressive bowel wall damage. The only treatments effective in achieving endoscopic remission are […]

Read More
DETAIL
Jun
28

Right Patient, Right Treatment, Right Time: Utilizing Early, High-Efficacy Therapies to Improve Outcomes in RRMS

In this On Demand webcast, Drs. Fred Lublin, Joseph Berger, and Anne Cross share expert insights on improving outcomes in relapse remitting multiple sclerosis.

Read More
DETAIL
Jun
27

Keeping the Beat: Screening and Management of High-Risk Patients with Non-Valvular Atrial Fibrillation

  Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, projected to affect 12 million Americans by 2030. However, a significant number of AF cases, particularly non-valvular atrial fibrillation (NVAF) remain undiagnosed, putting patients at risk for severe cardiovascular (CV) complications, including increased risk of stroke. This CME Outfitters OnDemand webcast will feature expert […]

Read More
DETAIL
Jun
24

Targeted Therapy for HER2 and HER3-Positive Breast Cancer: Navigating the Evolving Treatment Landscape

Breast cancer (BC) is a heterogeneous disease with human epidermal growth factor receptor 2 (HER2) overexpression and/or amplification observed in 20%-30% of cases. HER2-positive (+) BC correlates with poor clinical outcomes unless appropriately treated with targeted therapy. Despite significant therapeutic advances, many patients experience disease progression with resistance to targeted agents developing over the course […]

Read More
DETAIL
Jun
23

Giving Shingles Immunization Your Best Shot: Implementing a Shingles Vaccination Protocol in Your Practice

Shingles, or herpes zoster, is a common secondary infection for older patients. Almost all individuals over the age of 50 are latently infected with varicella zoster virus (VZV) and therefore are at risk of developing shingles with reactivation of latent VZV. This CME Outfitters OnDemand webcast will focus on the burden imposed by shingles, improving […]

Read More
DETAIL
Jun
22

Beyond the Old Paradigms: Novel Approaches to the Treatment of Chronic Idiopathic Constipation

Chronic idiopathic constipation (CIC) affects 35 million adults in the United States, making it one of the most common gastrointestinal disorders. Despite the high prevalence, CIC is often underdiagnosed and undertreated, which exacts a functional, psychosocial, and economic toll on patients and their loved ones. The current treatment goal in CIC is multi-symptom relief, but […]

Read More
DETAIL
May
18

Streamlining the Journey to a Cure: Optimizing the Hepatitis C Virus Care Cascade

Recent studies have shown persistent gaps in the HCV care continuum, with underdiagnosis and undertreatment being the major barriers toward achieving the goal of eliminating HCV. With primary care clinicians and community health workers representing an important front-line resource for early screening and treatment for HCV infection, it is imperative to educate primary care providers […]

Read More
DETAIL